These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1122 related articles for article (PubMed ID: 29708786)
1. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI. Kitao A; Matsui O; Yoneda N; Kita R; Kozaka K; Kobayashi S; Gabata T AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786 [TBL] [Abstract][Full Text] [Related]
2. Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules. Kim JW; Lee CH; Kim SB; Park BN; Park YS; Lee J; Park CM J Magn Reson Imaging; 2017 Jun; 45(6):1599-1608. PubMed ID: 27726242 [TBL] [Abstract][Full Text] [Related]
3. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI. Suh YJ; Kim MJ; Choi JY; Park YN; Park MS; Kim KW AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994 [TBL] [Abstract][Full Text] [Related]
4. Gd-EOB-DTPA enhanced MRI nomogram model to differentiate hepatocellular carcinoma and focal nodular hyperplasia both showing iso- or hyperintensity in the hepatobiliary phase. Mao HY; Shen BQ; Zhang JY; Zhang T; Cai W; Fan YF; Wang XM; Yu YX; Hu CH BMC Med Imaging; 2024 Aug; 24(1):211. PubMed ID: 39134943 [TBL] [Abstract][Full Text] [Related]
5. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. Lee MH; Kim SH; Park MJ; Park CK; Rhim H AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534 [TBL] [Abstract][Full Text] [Related]
6. [Differentiation between hyperintense hepatocellular carcinoma and focal nodular hyperplasia in hepatobiliary phase with multimodal parameters of magnetic resonance imaging]. Lang Y; Ma CQ; Deng LW; Wang J; Liu C; Xiao SL; Deng J; Li Q; Liu WW; Yang DS; Li XM Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1069-1073. PubMed ID: 36727231 [No Abstract] [Full Text] [Related]
7. Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma. Wells ML; Hough DM; Fidler JL; Kamath PS; Poterucha JT; Venkatesh SK Abdom Radiol (NY); 2017 Nov; 42(11):2623-2631. PubMed ID: 28785785 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of morphological enhancement patterns in the hepatobiliary phase of gadoxetic acid-enhanced MRI to distinguish focal nodular hyperplasia from hepatocellular adenoma. Bilreiro C; Soler JC; Ayuso JR; Caseiro-Alves F; Ayuso C Radiol Med; 2021 Nov; 126(11):1379-1387. PubMed ID: 34287759 [TBL] [Abstract][Full Text] [Related]
9. Gd-EOB-DTPA MRI for focal nodular hyperplasia-like lesions in pediatric cancer survivors. Gu K; Jeon TY; Yoo SY; Kim JH Eur Radiol; 2021 Jan; 31(1):283-291. PubMed ID: 32797310 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the arterial enhancement pattern of focal liver lesions by multiple arterial phase magnetic resonance imaging: comparison between hepatocellular carcinoma and focal nodular hyperplasia. Gatti M; Calandri M; Bergamasco L; Darvizeh F; Grazioli L; Inchingolo R; Ippolito D; Rousset S; Veltri A; Fonio P; Faletti R Radiol Med; 2020 Apr; 125(4):348-355. PubMed ID: 31916102 [TBL] [Abstract][Full Text] [Related]
11. Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience. Grieser C; Steffen IG; Kramme IB; Bläker H; Kilic E; Perez Fernandez CM; Seehofer D; Schott E; Hamm B; Denecke T Eur Radiol; 2014 Jun; 24(6):1339-48. PubMed ID: 24658870 [TBL] [Abstract][Full Text] [Related]
12. Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia. Cannella R; Rangaswamy B; Minervini MI; Borhani AA; Tsung A; Furlan A AJR Am J Roentgenol; 2019 Mar; 212(3):538-546. PubMed ID: 30557050 [TBL] [Abstract][Full Text] [Related]
13. Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study. Nowicki TK; Markiet K; Izycka-Swieszewska E; Dziadziuszko K; Studniarek M; Szurowska E BMC Gastroenterol; 2018 Jan; 18(1):10. PubMed ID: 29334905 [TBL] [Abstract][Full Text] [Related]
14. Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis. Choi JY; Lee HC; Yim JH; Shim JH; Lim YS; Shin YM; Yu ES; Suh DJ J Gastroenterol Hepatol; 2011 Jun; 26(6):1004-9. PubMed ID: 21251063 [TBL] [Abstract][Full Text] [Related]
16. Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis. Alamri TM; Cerny M; Al Shaikh M; Billiard JS; Olivié D; Chagnon M; Tang A Abdom Radiol (NY); 2023 Mar; 48(3):874-885. PubMed ID: 36528729 [TBL] [Abstract][Full Text] [Related]
18. Differentiating malignant from benign hyperintense nodules on unenhanced T1-weighted images in patients with chronic liver disease: using gadoxetic acid-enhanced and diffusion-weighted MR imaging. Moon JY; Kim SH; Choi SY; Hwang JA; Lee JE; Lee J Jpn J Radiol; 2018 Aug; 36(8):489-499. PubMed ID: 29876721 [TBL] [Abstract][Full Text] [Related]
19. Value of discrepancy of the central scar-like structure between dynamic CT and gadoxetate disodium-enhanced MRI in differentiation of focal nodular hyperplasia and hepatocellular adenoma. Park HJ; Byun JH; Kang JH; Kang HJ; Yu E; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN Eur J Radiol; 2021 Jun; 139():109730. PubMed ID: 33930719 [TBL] [Abstract][Full Text] [Related]
20. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study. Kim SS; Kim SH; Song KD; Choi SY; Heo NH J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]